ArticleSignal transduction and targeted therapy2022

T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape.

Zhenyu Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.